Injectable Polidocanol Formulation for Non-Surgical Fat Reduction
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current surgical methods for removing fat, such as lipoplasty, pose significant risks including death, complications, infection, seromas, skin damage, thromboembolism, and fluid imbalances, highlighting the need for alternative procedures.
Innovation Solution
The development of pharmaceutical compositions and formulations containing polidocanol and a C3-C6 alcohol, administered via subcutaneous injections, to reduce regional fat and adipose tissue without invasive surgery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If surgical methods such as lipoplasty are used to remove fat, then fat removal effectiveness is improved, but patient safety and risk of complications worsen
Solution Approach 1:
The patent replaces mechanical surgical methods (lipoplasty, suction, incisions) with a chemical/pharmacological approach using injectable compositions containing polidocanol and other agents that dissolve and remove adipose tissue through biochemical mechanisms, thereby eliminating mechanical trauma and associated surgical risks
Solution Approach 2:
The patent introduces intermediary chemical agents (polidocanol, deoxycholate, phospholipase) that mediate the fat removal process by chemically interacting with and dissolving adipose tissue, serving as a bridge between the administrator and the target tissue without requiring direct mechanical contact or surgical intervention
2Productivity
If surgical methods are used for fat removal, then fat removal effectiveness is improved, but risk of infection and complications worsens
Solution Approach 1:
The patent replaces open surgical procedures that create incisions and expose tissue to external contaminants with a closed-system injectable approach, where the composition is delivered through needle injection and acts internally to dissolve fat, thereby preventing bacterial contamination and infection
Solution Approach 2:
The patent converts the potential harm of chemical irritation or inflammation into a beneficial effect by using controlled inflammatory responses to enhance fat cell destruction and removal, where the immune system's natural response is harnessed to improve rather than worsen outcomes
3Productivity
If surgical methods are used for fat removal, then fat removal effectiveness is improved, but risk of skin damage and fluid imbalance worsens
Solution Approach 1:
The patent applies the treatment locally and selectively by injecting the composition directly into specific adipose tissue deposits through targeted needle insertion, allowing precise control over treatment area and depth while sparing surrounding healthy tissues, skin, and fluid compartments from systemic effects
Solution Approach 2:
The patent replaces mechanical suction and physical manipulation that can damage skin and disrupt fluid balance with a biochemical dissolution process that occurs in situ, eliminating the need for large-volume fluid shifts and mechanical stress on skin and underlying structures
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The described method effectively reduces subcutaneous adipose tissue with minimal collateral damage to surrounding tissues, offering a safer alternative to traditional surgical methods.
Implementation Method 1
pharmaceutical compositions and formulations containing polidocanol and a C3-C6 alcohol, administered via subcutaneous injections, to reduce regional fat and adipose tissue
Implementation Method 2
The described method effectively reduces subcutaneous adipose tissue with minimal collateral damage to surrounding tissues
Data Source
AI summary
Described herein, inter alia, are compositions, formulations, methods, and systems for reducing regional fat deposits and treating fat-related conditions.